|Over a month ago|
Blonder Tongue Laboratories trading resumes 15:0003/2603/26/20
Blonder Tongue Laboratories postpones FY19 earnings release » 14:4703/2603/26/20
Blonder Tongue Laboratories announced that it is postponing its previously announced release of its fourth quarter and fiscal 2019 earnings results, originally scheduled for Friday, March 27, 2020 prior to market opening and the related teleconference, originally scheduled for Friday, March 27, 2020 at 11:00 a.m. Eastern Time. "The COVID-19 outbreak and related developments make it necessary for the company to delay the filing of its Annual Report on Form 10-K and, as a result, the company believes that postponing the earnings release and teleconference is appropriate under the circumstances. The Securities and Exchange Commission has provided regulatory relief and related guidance regarding filings required to be make under applicable securities laws and SEC rules, and the company has filed a Current Report on Form 8-K to indicate that it is relying on that relief to extend the time for filing its Annual Report on Form 10-K. The company will announce a new date for the release and teleconference at the appropriate time," the company said.
Blonder Tongue Laboratories trading halted, news pending 14:3103/2603/26/20
|Over a quarter ago|
Blonder Tongue Laboratories names Edward Grauch as CEO » 16:4712/2612/26/19
Blonder Tongue Laboratories announced that the company's board has promoted Edward "Ted" Grauch to CEO of the company, effective January 1, 2020. Mr. Grauch will also retain his existing title of President. Ted will maintain his focus on developing the company's product strategy, sales, marketing, and technology activities, while also assuming overall management responsibility for the company's day-to-day activities. The heads of each of the company's four departments will be reporting directly to Ted.